Schrödinger to Present at Morgan Stanley Global Healthcare Conference
Schrödinger (SDGR), a company revolutionizing drug and materials discovery with its physics-based computational platform, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. The company's management will engage in a fireside chat on Wednesday, September 4, 2024, at 3:20 p.m. ET.
Investors and interested parties can access the live webcast of the presentation through the 'Investors' section of Schrödinger's website. The recorded session will remain available for approximately 90 days after the event, providing an extended opportunity for those unable to attend the live presentation to gain insights into the company's developments and strategies.
Schrödinger (SDGR), un'azienda che sta rivoluzionando la scoperta di farmaci e materiali con la sua piattaforma computazionale basata sulla fisica, ha annunciato la sua partecipazione alla 22a Conferenza Annuale Globale sulla Salute di Morgan Stanley. La direzione dell'azienda parteciperà a una chiacchierata informale mercoledì 4 settembre 2024, alle 15:20 ET.
Gli investitori e le parti interessate possono accedere al webcast dal vivo della presentazione attraverso la sezione 'Investitori' del sito web di Schrödinger. La registrazione della sessione rimarrà disponibile per circa 90 giorni dopo l'evento, offrendo un'opportunità estesa a coloro che non possono partecipare alla presentazione dal vivo per ottenere informazioni sugli sviluppi e le strategie dell'azienda.
Schrödinger (SDGR), una compañía que está revolucionando el descubrimiento de fármacos y materiales con su plataforma computacional basada en la física, ha anunciado su participación en la 22ª Conferencia Anual Global de Salud de Morgan Stanley. La gestión de la compañía participará en una charla informal el miércoles 4 de septiembre de 2024, a las 3:20 p.m. ET.
Los inversores y las partes interesadas pueden acceder a la transmisión en vivo de la presentación a través de la sección 'Inversores' en el sitio web de Schrödinger. La sesión grabada estará disponible durante aproximadamente 90 días después del evento, proporcionando una oportunidad extendida para aquellos que no puedan asistir a la presentación en vivo de obtener información sobre los desarrollos y estrategias de la compañía.
슈뢰딩거 (SDGR)는 물리학 기반의 컴퓨팅 플랫폼으로 약물 및 소재 발견을 혁신하고 있는 회사로, 모건 스탠리 제22회 연례 글로벌 헬스케어 콘퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2024년 9월 4일 수요일 오후 3시 20분 ET에 비공식 대화에 참여할 예정입니다.
투자자 및 관심 있는 분들은 슈뢰딩거 웹사이트의 '투자자' 섹션을 통해 실시간 웨비나를 시청할 수 있습니다. 녹화된 세션은 이벤트 이후 약 90일 동안 이용 가능하여, 라이브 프레젠테이션에 참석할 수 없는 사람들도 회사의 개발 사항 및 전략에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
Schrödinger (SDGR), une entreprise révolutionnant la découverte de médicaments et de matériaux grâce à sa plateforme computationnelle basée sur la physique, a annoncé sa participation à la 22e Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. La direction de l'entreprise participera à une discussion informelle le mercredi 4 septembre 2024, à 15h20 ET.
Les investisseurs et les parties intéressées peuvent accéder au webinaire en direct de la présentation via la section 'Investisseurs' sur le site web de Schrödinger. La session enregistrée restera disponible pendant environ 90 jours après l'événement, offrant ainsi une opportunité prolongée pour ceux qui ne peuvent pas assister à la présentation en direct de se pencher sur les développements et stratégies de l'entreprise.
Schrödinger (SDGR), ein Unternehmen, das die Entdeckung von Medikamenten und Materialien mit seiner physikbasierten Computerplattform revolutioniert, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley angekündigt. Das Management des Unternehmens wird am Mittwoch, den 4. September 2024, um 15:20 Uhr ET an einem informellen Gespräch teilnehmen.
Investoren und Interessierte können über den Bereich 'Investoren' auf der Website von Schrödinger auf das Live-Webcast der Präsentation zugreifen. Die aufgezeichnete Sitzung wird etwa 90 Tage nach der Veranstaltung verfügbar bleiben und bietet so eine längere Gelegenheit für diejenigen, die nicht an der Live-Präsentation teilnehmen können, um Einblicke in die Entwicklungen und Strategien des Unternehmens zu gewinnen.
- None.
- None.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.
About Schrödinger
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger’s multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.
Founded in 1990, Schrödinger has approximately 850 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240814223528/en/
Allie Nicodemo
Schrödinger, Inc.
allie.nicodemo@schrodinger.com
617-356-2325
Source: Schrödinger
FAQ
When is Schrödinger (SDGR) presenting at the Morgan Stanley Global Healthcare Conference?
How can I watch Schrödinger's (SDGR) presentation at the Morgan Stanley conference?
How long will Schrödinger's (SDGR) Morgan Stanley conference presentation be available to view?
What type of presentation will Schrödinger (SDGR) give at the Morgan Stanley Healthcare Conference?
